Loading Map…
This bill aims to lower prescription drug prices in the U.S. by tying them to prices in other well‑developed countries and cracking down on unfair industry practices. It tells federal health agencies to quickly set target prices so U.S. patients pay amounts similar to what people pay abroad, and to help patients buy directly from drugmakers at those prices. It also asks trade and commerce officials to study whether drug company behaviors are unfair, like making U.S. patients shoulder most of the world’s research costs, and report back within 180 days.
Key points:
